PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
Wang Q, Shi YL, Zhou K, Wang LL, Yan ZX, Liu YL, Xu LL, Zhao SW, Chu HL, Shi TT, Ma QH, Bi J.
Wang Q, et al. Among authors: liu yl.
Cell Death Dis. 2018 Jul 3;9(7):739. doi: 10.1038/s41419-018-0776-6.
Cell Death Dis. 2018.
PMID: 29970892
Free PMC article.